Links to publications that use this product:
Charron et al. In vivo administration of corticotropin-releasing hormone at remote intervals following ischemia enhances CA1 neuronal survival and recovery of spatial memory impairments: A role for opioid receptors
Behav Brain Res. 2008 Mar 17;188(1):125-35.
Lebrethon et al. Effects of In Vivo and In Vitro Administration of Ghrelin, Leptin and Neuropeptide Mediators on Pulsatile Gonadotrophin-Releasing Hormone Secretion from Male Rat Hypothalamus Before and After Puberty
J Neuroendocrinol. 2007 Mar;19(3):181-8.
Tu et al. Corticotropin-Releasing Hormone Receptor (CRHR)1 and CRHR2 Are Both Trafficking and Signaling Receptors for Urocortin
Mol Endocrinol. 2007 Mar;21(3):700-11.
Plamondon et al. The CRH1 antagonist CP154,526 failed to alter ischemia-induced neurodegeneration and spatial memory deficits in rats but inhibited behavioral activity in the novel open field.
Behav Brain Res. 2006 Jan 6;166(1):85-92.
Samson et al. Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion.
Endocrine. 2003 Feb-Mar;20(1-2):59-66.
Correia et al. Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure.
Hypertension. 2001 Sep;38(3):384-8.
Leitch et al. Vasodilator Actions of Urocortin and Related Peptides in the Human Perfused Placenta in Vitro
J Clin Endocrinol Metab. 1998 Dec;83(12):4510-3.
For best results and reproducibility, rehydrate peptide just before use. Do not attempt to weigh out smaller portions. Do not refreeze any unused portions.